Review
Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials
- PMID: 339354
Item in Clipboard
Review
Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials
Semin Oncol.
1977 Dec.
No abstract available
Similar articles
-
Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.Cancer Treat Rep. 1978 Nov;62(11):1651-61. Cancer Treat Rep. 1978. PMID: 310339 Clinical Trial.
-
Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.Ann N Y Acad Sci. 1976;277(00):339-44. doi: 10.1111/j.1749-6632.1976.tb41712.x. Ann N Y Acad Sci. 1976. PMID: 1069553 No abstract available.
-
Levamisole in squamous cell carcinoma of the head and neck.Cancer Treat Rep. 1979 Jun;63(6):983-90. Cancer Treat Rep. 1979. PMID: 380804 Clinical Trial.
-
Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.J Maxillofac Surg. 1978 May;6(2):75-93. doi: 10.1016/s0301-0503(78)80074-5. J Maxillofac Surg. 1978. PMID: 353210 Review.
-
Immunobiology of head and neck cancer: basic concepts.Head Neck Surg. 1979 Sep-Oct;2(1):42-55. doi: 10.1002/hed.2890020107. Head Neck Surg. 1979. PMID: 400659 Review.
Cited by
-
Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.Cancer Immunol Immunother. 1986;21(3):226-32. doi: 10.1007/BF00199366. Cancer Immunol Immunother. 1986. PMID: 3457630 Free PMC article.